ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

NCT05878860 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
97
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Atsena Therapeutics Inc.